Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 42, 2014, Pages E4513-E4522

  Kreher, Stephan ^a,b   Bouhlel, M Amine ^c   Cauchy, Pierre ^d   Lamprecht, Björn ^a,b,e   Li, Shuang ^a,b   Grau, Michael ^f   Hummel, Franziska ^a,b   Köchert, Karl ^a,b   Anagnostopoulos, Ioannis ^b   Jöhrens, Korinna ^b   Hummel, Michael ^b,e   Hiscott, John ^g   Wenzel, Sören Sebastian ^b   Lenz, Peter ^f   Schneider, Markus ^h   Küppers, Ralf ^h   Scheidereit, Claus ^a   Giefing, Maciej ^i,j   Siebert, Reiner ⁱ   Rajewsky, Klaus ^a   Lenz, Georg ^b   Cockerill, Peter N ^d   Janz, Martin ^a,b   Dörken, Bernd ^a,b,e   Bonifer, Constanze ^d   Mathas, Stephan ^a,b,e   more..

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

^g Vaccine and Gene Therapy Institute of Florida   (United States)

^h UNIVERSITY OF DUISBURG ESSEN   (Germany)

ⁱ UNIVERSITY OF KIEL   (Germany)

^j INSTITUTE OF HUMAN GENETICS   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYRIBONUCLEASE I; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 5; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; CHEMOKINE; CHROMATIN; CYTOKINE; INTERFERON REGULATORY FACTOR; IRF5 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; CHROMATIN; CLASSICAL HODGKIN LYMPHOMA; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATION; LYMPHOMAGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN MOTIF; REGULATORY MECHANISM; ANIMAL; B LYMPHOCYTE; CELL LINEAGE; CHEMOTAXIS; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HODGKIN DISEASE; LYMPHOMA; METABOLISM; MONONUCLEAR CELL; NONHODGKIN LYMPHOMA; PLASMID; SPLEEN; TUMOR CELL LINE;

AMINO ACID MOTIFS; ANIMALS; B-LYMPHOCYTES; CELL LINE, TUMOR; CELL LINEAGE; CHEMOKINES; CHEMOTAXIS; CHROMATIN; CYTOKINES; DEOXYRIBONUCLEASE I; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HODGKIN DISEASE; HUMANS; INFLAMMATION; INTERFERON REGULATORY FACTORS; LEUKOCYTES, MONONUCLEAR; LYMPHOMA; LYMPHOMA, NON-HODGKIN; MICE; NF-KAPPA B; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; SPLEEN; TRANSCRIPTION FACTOR AP-1;

EID: 84908075195     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1406985111     Document Type: Article

References (49)

1. Rui L, Schmitz R, Ceribelli M, Staudt LM (2011) Malignant pirates of the immune system. Nat Immunol 12(10):933-940.
2. Rosenbauer F, Tenen DG (2007) Transcription factors in myeloid development: Balancing differentiation with transformation. Nat Rev Immunol 7(2):105-117.
3. Mullighan CG (2013) Genome sequencing of lymphoid malignancies. Blood 122(24):3899-3907.
4. Cobaleda C, Jochum W, Busslinger M (2007) Conversion of mature B cells into T cells by dedifferentiation to uncommitted progenitors. Nature 449(7161):473-477.
5. Cobaleda C, Busslinger M (2008) Developmental plasticity of lymphocytes. Curr Opin Immunol 20(2):139-148.
6. Küppers R (2009) The biology of Hodgkin's lymphoma. Nat Rev Cancer 9(1):15-27.
7. Mathas S, et al. (2006) Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma. Nat Immunol 7(2):207-215.
8. Lamprecht B, et al. (2010) Derepression of an endogenous long terminal repeat activates the CSF1R proto-oncogene in human lymphoma. Nat Med 16(5):571-579.
9. Cockerill PN (2011) Structure and function of active chromatin and DNase I hypersensitive sites. FEBS J 278(13):2182-2210.
10. Ptasinska A, et al. (2012) Depletion of RUNX1/ETO in t(8;21) AML cells leads to ge-nome- wide changes in chromatin structure and transcription factor binding. Leukemia 26(8):1829-1841.
11. Stergachis AB, et al. (2013) Developmental fate and cellular maturity encoded in human regulatory DNA landscapes. Cell 154(4):888-903.
12. Takaoka A, et al. (2005) Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 434(7030):243-249.
13. Tamura T, Yanai H, Savitsky D, Taniguchi T (2008) The IRF family transcription factors in immunity and oncogenesis. Annu Rev Immunol 26:535-584.
14. Steidl C, et al. (2011) MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers. Nature 471(7338):377-381.
15. Rui L, et al. (2010) Cooperative epigenetic modulation by cancer amplicon genes. Cancer Cell 18(6):590-605.
16. Leddin M, et al. (2011) Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells. Blood 117(10):2827-2838.
17. Heinz S, et al. (2010) Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol Cell 38(4):576-589.
18. Matthias P, Rolink AG (2005) Transcriptional networks in developing and mature B cells. Nat Rev Immunol 5(6):497-508.
19. Overbeck BM, et al. (2012) ETS1 encoding a transcription factor involved in B-cell differentiation is recurrently deleted and down-regulated in classical Hodgkin's lymphoma. Haematologica 97(10):1612-1614.
20. Lichtinger M, et al. (2012) RUNX1 reshapes the epigenetic landscape at the onset of haematopoiesis. EMBO J 31(22):4318-4333.
21. Falini B, et al. (2000) A monoclonal antibody (MUM1p) detects expression of the MUM1/IRF4 protein in a subset of germinal center B cells, plasma cells, and activated T cells. Blood 95(6):2084-2092.
22. Küppers R, et al. (2003) Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling. J Clin Invest 111(4):529-537.
23. Barnes BJ, Moore PA, Pitha PM (2001) Virus-specific activation of a novel interferon regulatory factor, IRF-5, results in the induction of distinct interferon alpha genes. J Biol Chem 276(26):23382-23390.
24. Barnes BJ, Kellum MJ, Field AE, Pitha PM (2002) Multiple regulatory domains of IRF-5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol Cell Biol 22(16):5721-5740.
25. Chen W, et al. (2008) Insights into interferon regulatory factor activation from the crystal structure of dimeric IRF5. Nat Struct Mol Biol 15(11):1213-1220.
26. Barnes BJ, et al. (2004) Global and distinct targets of IRF-5 and IRF-7 during innate response to viral infection. J Biol Chem 279(43):45194-45207.
27. Génin P, Algarté M, Roof P, Lin R, Hiscott J (2000) Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J Immunol 164(10):5352-5361.
28. Mathas S, et al. (2002) Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B. EMBO J 21(15):4104-4113.
29. Lin R, Yang L, Arguello M, Penafuerte C, Hiscott J (2005) A CRM1-dependent nuclear export pathway is involved in the regulation of IRF-5 subcellular localization. J Biol Chem 280(4):3088-3095.
30. Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284(5412):309-313.
31. Lamprecht B, Bonifer C, Mathas S (2010) Repeat-element driven activation of proto-oncogenes in human malignancies. Cell Cycle 9(21):4276-4281.
32. Janz M, et al. (2006) Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3), which promotes viability of Hodgkin/Reed-Sternberg cells. Blood 107(6):2536-2539.
33. Boyle AP, et al. (2008) High-resolution mapping and characterization of open chromatin across the genome. Cell 132(2):311-322.
34. Neph S, et al. (2012) An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489(7414):83-90.
35. Watanabe M, et al. (2003) AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells. Am J Pathol 163(2):633-641.
36. Juszczynski P, et al. (2007) The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA 104(32):13134-13139.
37. Habelhah H, et al. (2004) Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J 23(2):322-332.
38. Krappmann D, et al. (1999) Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells. Oncogene 18(4):943-953.
39. Hjalgrim H, et al. (2003) Characteristics of Hodgkin's lymphoma after infectious mononucleosis. N Engl J Med 349(14):1324-1332.
40. Krausgruber T, et al. (2010) IRF5 is required for late-phase TNF secretion by human dendritic cells. Blood 115(22):4421-4430.
41. Graham RR, et al.; Argentine and Spanish Collaborative Groups (2006) A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus. Nat Genet 38(5):550-555.
42. Krausgruber T, et al. (2011) IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12(3):231-238.
43. Schoenemeyer A, et al. (2005) The interferon regulatory factor, IRF5, is a central mediator of toll-like receptor 7 signaling. J Biol Chem 280(17):17005-17012.
44. Lenardo MJ, Fan CM, Maniatis T, Baltimore D (1989) The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57(2):287-294.
45. Taniguchi T, Takaoka A (2002) The interferon-alpha/beta system in antiviral responses: A multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 14(1):111-116.
46. Stanelle J, Döring C, Hansmann ML, Küppers R (2010) Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood 116(20):4202-4211.
47. Brummelkamp TR, Bernards R, Agami R (2002) A system for stable expression of short interfering RNAs in mammalian cells. Science 296(5567):550-553.
48. Reynolds A, et al. (2004) Rational siRNA design for RNA interference. Nat Biotechnol 22(3):326-330.
49. Turatsinze JV, Thomas-Chollier M, Defrance M, van Helden J (2008) Using RSAT to scan genome sequences for transcription factor binding sites and cis-regulatory modules. Nat Protoc 3(10):1578-1588.